Cite
HARVARD Citation
Axelsson, M. et al. (2019). Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies. Acta neurologica Scandinavica. pp. 422-427. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Axelsson, M. et al. (2019). Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies. Acta neurologica Scandinavica. pp. 422-427. [Online].